708(top 15%)
articles
27.8K(top 10%)
citations
145(top 14%)
★★ articles
4(top 13%)
★★★ articles
1.5(top 49%)
Avg IF
84(top 8%)
H-Index
141(top 9%)
G-Index
267
journals

Most Cited Articles of Princess Margaret Hospital in 2011

TitleJournalYearCitations
Initial genome sequencing and analysis of multiple myelomaNature20111.1K
Palliative radiotherapy for bone metastases: an ASTRO evidence-based guidelineInternational Journal of Radiation Oncology Biology Physics2011614
Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapyNature Medicine2011553
Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity studyBMJ, The2011539
Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiformeJournal of Experimental Medicine2011527
An overview of the c-MET signaling pathwayTherapeutic Advances in Medical Oncology2011492
Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infectionClinical Infectious Diseases2011478
Inhibition of mitochondrial translation as a therapeutic strategy for human acute myeloid leukemiaCancer Cell2011425
Toxicity of adjuvant endocrine therapy in postmenopausal breast cancer patients: a systematic review and meta-analysisJournal of the National Cancer Institute2011423
Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trialLancet, The2011405
EGFR mutations and lung cancerAnnual Review of Pathology: Mechanisms of Disease2011387
Evolution of human BCR-ABL1 lymphoblastic leukaemia-initiating cellsNature2011383
Active surveillance of small renal masses: progression patterns of early stage kidney cancerEuropean Urology2011339
Carnitine palmitoyltransferase 1C promotes cell survival and tumor growth under conditions of metabolic stressGenes and Development2011324
Results from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with FLT3 mutant AML in first relapseBlood2011323
Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancerGynecologic Oncology2011280
Outcomes of small renal mass needle core biopsy, nondiagnostic percutaneous biopsy, and the role of repeat biopsyEuropean Urology2011276
Phase II study of temsirolimus in women with recurrent or metastatic endometrial cancer: a trial of the NCIC Clinical Trials GroupJournal of Clinical Oncology2011274
Spread of methicillin-resistant Staphylococcus aureus between the community and the hospitals in Asian countries: an ANSORP studyJournal of Antimicrobial Chemotherapy2011259
The impact of cytoreductive nephrectomy on survival of patients with metastatic renal cell carcinoma receiving vascular endothelial growth factor targeted therapyJournal of Urology2011258
Clinical validation of cutoff target ranges in newborn screening of metabolic disorders by tandem mass spectrometry: a worldwide collaborative projectGenetics in Medicine2011250
Drug resistance in metastatic castration-resistant prostate cancerNature Reviews Clinical Oncology2011243
PTEN-inducible kinase 1 (PINK1)/Park6 is indispensable for normal heart functionProceedings of the National Academy of Sciences of the United States of America2011241
MiR-218 suppresses nasopharyngeal cancer progression through downregulation of survivin and the SLIT2-ROBO1 pathwayCancer Research2011228
Phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small-cell lung cancer: primary analysis of radiation therapy oncology group study RTOG 0214Journal of Clinical Oncology2011228